Administration of Zidovudine during Late Pregnancy and Delivery to Prevent Perinatal HIV Transmission - Thailand, 1996-1998

Morbidity and Mortality Weekly Report

Volumn 47, Issue 8, 1998, Pages 151-154

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

ARTICLE; DELIVERY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PREGNANCY COMPLICATION; THAILAND; TREATMENT OUTCOME;

ANTI-HIV AGENTS; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; THAILAND; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0032489116     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. World Health Organization. Global AIDS surveillance - part I. Wkly Epidemiol Rec 1997;72: 357-60.
2. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from motherto infant. N Engl J Med 1996;335:1621-9.
3. CDC. Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus. MMWR 1994;43 (no. RR-11).
4. Shaffer N, Bhiraleus P, Chinayon P, et al. High viral load predicts perinatal HIV-1 subtype E transmission, Bangkok, Thailand [Abstract]. Vancouver, Canada: XIth International Conference on AIDS, July 1996.
5. Bertolli J, St. Louis ME, Simonds RJ, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis 1996;174:722-6.